Deep Track Capital, LP 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:40 am Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 609,900 1.320% |
-3,486,552 (-85.11%) |
Filing |
| 2024-11-14 09:13 am Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 4,096,452 7.880% |
1,812,080 (+79.33%) |
Filing |
| 2024-02-14 08:43 am Sale |
2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 2,284,372 5.340% |
-372,529 (-14.02%) |
Filing |
| 2023-02-14 08:32 am Purchase |
2022-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 2,656,901 8.200% |
756,901 (+39.84%) |
Filing |
| 2022-02-14 08:56 am Purchase |
2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 1,900,000 5.910% |
100,000 (+5.56%) |
Filing |
| 2021-11-04 5:02 pm Purchase |
2021-10-29 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 1,800,000 5.690% |
1,800,000 (New Position) |
Filing |